Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,638 | -19,794 | -54,659 | -38,713 | -24,430 |
| Depreciation Amortization | 279 | 133 | 423 | 298 | 189 |
| Accounts receivable | 8,053 | -3,483 | 799 | -682 | -4,161 |
| Accounts payable and accrued liabilities | 8,105 | 4,500 | 10,210 | 9,248 | 7,142 |
| Other Working Capital | 11,609 | -2,549 | -8,331 | -7,480 | -7,834 |
| Other Operating Activity | -3,828 | 4,146 | -3,490 | -4,140 | -361 |
| Operating Cash Flow | $-34,420 | $-17,047 | $-55,048 | $-41,469 | $-29,455 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -536 | -218 | -628 | -438 | -358 |
| Purchase Of Investment | -125,520 | N/A | -49,347 | -44,385 | -46,692 |
| Sale Of Investment | 43,348 | 8,161 | 8,446 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -2 | -1 | -1 |
| Investing Cash Flow | $-82,708 | $7,943 | $-41,531 | $-44,824 | $-47,051 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 129,440 | 129,440 | 2,215 | 146 | N/A |
| Financing Cash Flow | $129,440 | $129,440 | $2,215 | $146 | $N/A |
| Beginning Cash Position | 43,044 | 43,044 | 137,408 | 137,408 | 137,408 |
| End Cash Position | 55,356 | 163,380 | 43,044 | 51,261 | 60,902 |
| Net Cash Flow | $12,312 | $120,336 | $-94,364 | $-86,147 | $-76,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,420 | -17,047 | -55,048 | -41,469 | -29,455 |
| Capital Expenditure | -536 | -218 | -628 | -438 | -358 |
| Free Cash Flow | -34,956 | -17,265 | -55,676 | -41,907 | -29,813 |